Cargando…

The Role of Mass Drug Administration of Antimalarials

Detalles Bibliográficos
Autor principal:	Alonso, Pedro L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416970/ https://www.ncbi.nlm.nih.gov/pubmed/32618264 http://dx.doi.org/10.4269/ajtmh.20-0729

Ejemplares similares

Antimalarial mass drug administration in large populations and the evolution of drug resistance
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study
por: Galatas, Beatriz, et al.
Publicado: (2021)

Reflections on a Community Engagement Strategy for Mass Antimalarial Drug Administration in Cambodia
por: Peto, Thomas J., et al.
Publicado: (2018)

Natural Products as Sources of Antimalarial Drugs
por: Uzor, Philip F., et al.
Publicado: (2020)

The Tragedy Caused by Fake Antimalarial Drugs
por: Ambroise-Thomas, Pierre
Publicado: (2012)

Effect of mass dihydroartemisinin–piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance
por: Gupta, Himanshu, et al.
Publicado: (2020)

Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs
por: Martí Coma-Cros, Elisabet, et al.
Publicado: (2018)

Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations
por: Parker, Daniel M, et al.
Publicado: (2019)

Synthetic Antimalarials
Publicado: (1955)

Optimizing Delivery of Mass Drug Administration for Schistosomiasis
por: Friedman, Jennifer F.
Publicado: (2019)

The Antimalarial Operations at Mian Mir
Publicado: (1904)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Modern management of antimalarial usage and retinopathy
por: Marmor, Michael F.
Publicado: (2017)

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs
por: Secor, W. Evan
Publicado: (2019)

STARTER checklist for antimalarial therapeutic efficacy reporting
por: Plucinski, Mateusz M., et al.
Publicado: (2022)

STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
por: Plucinski, Mateusz, et al.
Publicado: (2022)

Oral Administration of Clinically Relevant Antimalarial Drugs Does Not Modify the Murine Gut Microbiota
por: Denny, Joshua E., et al.
Publicado: (2019)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria
por: Evans, Darin S.
Publicado: (2020)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

Antimalarial drug resistance: An overview
por: Antony, Hiasindh Ashmi, et al.
Publicado: (2016)

Antimalarial drug and renal toxicity
por: Wiwanitkit, Viroj
Publicado: (2015)

Herbicidal properties of antimalarial drugs
por: Corral, Maxime G., et al.
Publicado: (2017)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

Antimalarial drug discovery: progress and approaches
por: Siqueira-Neto, Jair L, et al.
Publicado: (2023)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
por: Bacon, David J, et al.
Publicado: (2007)

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

The rationale and plan for creating a World Antimalarial Resistance Network (WARN)
por: Sibley, Carol Hopkins, et al.
Publicado: (2007)

Intermittent Preventive Treatment with Sulfadoxine–Pyrimethamine: More than Just an Antimalarial?
por: Gutman, Julie, et al.
Publicado: (2017)

Comparative cardiac effects of antimalarial drug halofantrine with or without concomitant administration of kolanut or fluconazole in healthy volunteers
por: Adedapo, Aduragbenro DA, et al.
Publicado: (2023)

New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2020)

Comparing Highly Efficacious Antimalarial Drugs
por: Sutherland, Colin J
Publicado: (2008)

A database of antimalarial drug resistance
por: Sibley, Carol Hopkins, et al.
Publicado: (2006)

Antimalarial drugs: unexpected evolutionary consequences
por: Schneider, Petra, et al.
Publicado: (2010)

Trends in Antimalarial Drug Use in Africa
por: Flegg, Jennifer A., et al.
Publicado: (2013)

The global challenge of antimalarial drug resistance
por: Ringwald, Pascal, et al.
Publicado: (2012)

The assessment of antimalarial drug efficacy in-vivo
por: White, Nicholas J.
Publicado: (2022)

The genomic architecture of antimalarial drug resistance
por: Cowell, Annie N, et al.
Publicado: (2019)

Antimalarials – old drugs are new again
por: Woźniacka, Anna
Publicado: (2021)

The Role of the Iron Protoporphyrins Heme and Hematin in the Antimalarial Activity of Endoperoxide Drugs
por: Quadros, Helenita C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s4gvalmft668835clmaqhnc4t1